TipRanks
Go Ultimate55% OFF

Keith Regnante Insider Profile

11 Followers

Keith Regnante, CFO at Keros Therapeutics, holds 39.26K shares in Keros Therapeutics (Ticker: KROS), holds 29.19K shares in Wave Life Sciences (Ticker: WVE). Most recently, Keith Regnante Sold ― shares of Keros Therapeutics on Feb 20, 2026 for an estimated value of $77.48K.

Keith Regnante's Trading History

KROS
Keros Therapeutics
Feb 20, 2026CFOInformative Sell77.48K$433.44K
WVE
Wave Life Sciences
Mar 11, 2019CFOUninformative Buy―$104.78K

You May Also Like

Keith Regnante insider profile FAQ

What stocks does Keith Regnante hold?
Keith Regnante holds: KROS, WVE stocks.
What was Keith Regnante’s latest transaction?
Keith Regnante’s latest transaction was an Informative Sell of $77.48K.
What is Keith Regnante's role in Keros Therapeutics?
Keith Regnante's role in Keros Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.